Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system characterized by demyelination and neurodegeneration. Beyond neurological and physical disability, people with MS frequently experience clinically relevant disturbances in sleep. Symptom variability and unpredictable disease course can generate persistent anxiety about future episodes, commonly framed as fear of relapse (FoR). The authors highlight a knowledge gap in how biopsychosocial risk factors such as childhood maltreatment (CM) and sleep quality relate to FoR in MS.
This study used cross-sectional data collected via an online survey. The investigators administered three validated self-report instruments: the Pittsburgh Sleep Quality Index (PSQI) to measure sleep quality, the Fear-of-Relapse Scale (FoR) to quantify anxiety about future relapses, and the Childhood Trauma Questionnaire (CTQ) to capture histories of childhood maltreatment. In addition to overall CTQ scores, the survey collected information on time points of exposure to different CM subtypes. Linear regression models were used to examine associations among the three constructs and to test interaction effects between CM and sleep in predicting FoR.
The analytic sample comprised N = 48 participants who completed the online survey. The research received ethics approval from the Review Board for Issues of Ethics in Scientific Research at the Department of Psychology, University of Innsbruck (Certificate of good standing, #45/2025). The authors confirmed that participant consent was obtained and that reporting followed relevant research guidelines. The manuscript is posted as a medRxiv preprint and has not been peer reviewed.
Linear regression analyses examined the primary associations between sleep quality and FoR and tested whether CM moderated the relationship between sleep and FoR. The study reports both analyses in the entire cohort and exploratory sex-stratified interaction tests. Specific model coefficients, confidence intervals, and p-values were not reported in the summary abstract; readers should consult the full preprint for complete statistical details.
The primary finding reported is a significant negative association between overall sleep quality (worse sleep) and fear of relapse (greater FoR) in the sample. In the total cohort, the interaction term representing CM × sleep was not a statistically significant predictor of FoR. Thus, while poorer sleep related to higher FoR overall, the combined effect of CM and sleep quality did not explain additional variance in FoR across the whole sample according to the authors' main analysis.
In exploratory, sex-stratified analyses the authors observed a significant interaction between CM and sleep among male participants, indicating that in men the relationship between sleep quality and FoR differed depending on CM history. The same interaction was not significant among female participants. The abstract does not provide subgroup sample sizes, effect sizes, or statistical detail for these exploratory tests, so the magnitude and robustness of the sex-specific interaction cannot be evaluated from the abstract alone.
The authors interpret their results to mean that a history of childhood maltreatment and impaired sleep quality may contribute additional psychosocial stressors that influence how people with MS manage their illness and perceive relapse risk. Given the observed association between poor sleep and higher fear of relapse, screening for and addressing sleep problems may be clinically relevant. The exploratory sex-specific interaction reported in males suggests potential heterogeneity in how early-life adversity interacts with current sleep to shape disease-related anxiety, meriting further investigation.
This report is a preprint and has not undergone peer review; findings should be considered preliminary. The study used a modest sample size (N = 48) and cross-sectional survey methods, limiting causal inference and generalizability. The abstract does not detail covariates included in regression models, nor does it report specific effect sizes or p-values for all analyses; those details were not reported in the abstract and should be sought in the full text. The authors call for additional research and translational efforts to expand prevention strategies and personalize care to address CM and sleep disturbances in people with MS.
The authors state that the datasets generated and analyzed during the study are available from the corresponding author on reasonable request. The preprint is posted on medRxiv and has not been certified by peer review. The authors declared no competing interests and confirmed that ethical approvals and participant consents were obtained (Review Board for Issues of Ethics in Scientific Research, Department of Psychology, University of Innsbruck; Certificate #45/2025).